Duration of Use of Highly Effective Reversible Contraception

• Status: Completed
• Trial end date: 2016-03-28
• Target enrollment: 0
• Participant gender: Female

Summary

To assess the proportion of women who use HERC for ≥2 years of duration

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Collaborator: University of Utah
• Treatments: Etonogestrel; Levonorgestrel

Criteria

Inclusion Criteria:

-Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012